These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3809855)

  • 41. Immunoadsorption--a new therapeutic possibility for multiple sclerosis?
    Schneidewind JM; Winkler R; Ramlow W; Tiess M; Hertel U; Sehland D
    Transfus Sci; 1998 Mar; 19 Suppl():59-63. PubMed ID: 10178697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).
    Höcker P; Stellamor V; Summer K; Mann M
    Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.
    Keegan M; König F; McClelland R; Brück W; Morales Y; Bitsch A; Panitch H; Lassmann H; Weinshenker B; Rodriguez M; Parisi J; Lucchinetti CF
    Lancet; 2005 Aug 13-19; 366(9485):579-82. PubMed ID: 16099294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].
    Noseworthy JH; Ebers GC; Vandervoort MK; Farquhar RE; Yetisir E; Roberts R
    Neurology; 2001 Dec; 57(12 Suppl 5):S31-5. PubMed ID: 11902593
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma exchange and immune complex diseases: the predictability of immune complexes removal to clinical response.
    Valbonesi M; Garelli S; Montani F; Manca F; Cantarella S
    Vox Sang; 1982 Jan; 42(1):27-32. PubMed ID: 6460383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Complex treatment of patients with multiple sclerosis].
    Dragon A
    Neurol Neurochir Pol; 1983; 17(3):347-52. PubMed ID: 6646325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute fulminant multiple sclerosis and plasma exchange.
    Jacquerye P; Ossemann M; Laloux P; Dive A; De Coene B
    Eur Neurol; 1999; 41(3):174-5. PubMed ID: 10202254
    [No Abstract]   [Full Text] [Related]  

  • 48. Partial plasma protein replacement in therapeutic plasma exchange.
    McLeod BC; Sassetti RJ; Stefoski D; Davis FA
    J Clin Apher; 1983; 1(2):115-8. PubMed ID: 6681482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic apheresis in multiple sclerosis and other central nervous system disorders.
    Khatri BO
    Ther Apher; 2000 Aug; 4(4):263-70. PubMed ID: 10975471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The determination of sialic acids in the lymphocytes of multiple sclerosis patients].
    Nehrych TI
    Lik Sprava; 2000; (3-4):48-51. PubMed ID: 10921260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclophosphamide and plasma exchange in multiple sclerosis.
    Lancet; 1991 Apr; 337(8748):1033-4. PubMed ID: 1673181
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term use of antecubital veins for plasma exchange. The Canadian Cooperative Multiple Sclerosis Study Group.
    Noseworthy JH; Shumak KH; Vandervoort MK
    Transfusion; 1989 Sep; 29(7):610-3. PubMed ID: 2672434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour.
    Palm M; Behm E; Schmitt E; Buddenhagen F; Hitzschke B; Kracht M; Kundt G; Meyer-Rienecker H; Klinkmann H
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):283-96. PubMed ID: 1751678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma exchange: aid to therapy of multiple sclerosis?
    van den Noort S; Waksman BH
    Neurology; 1980 Oct; 30(10):1111. PubMed ID: 7191501
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acupuncture as a therapeutic aid in multiple sclerosis].
    Pala R; Zibetti A; Rogora GA
    Minerva Med; 1978 Dec; 69(62):4343-51. PubMed ID: 745800
    [No Abstract]   [Full Text] [Related]  

  • 56. Transfer factor treatment of multiple sclerosis. A pilot study.
    Jersild C; Platz P; Svejgaard A; Pedersen L; Kam-Hansen S; Raun N; Mellerup E; Jacobsen B; Linnemann F; Westh P
    Acta Neurol Scand Suppl; 1977; 63():253-64. PubMed ID: 322441
    [No Abstract]   [Full Text] [Related]  

  • 57. Reaction time deficit in multiple sclerosis.
    Elsass P; Zeeberg I
    Acta Neurol Scand; 1983 Oct; 68(4):257-61. PubMed ID: 6659866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistopathology to guide multiple sclerosis treatment.
    Opdenakker G
    Lancet; 2005 Aug 13-19; 366(9485):526-7. PubMed ID: 16099274
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma exchange for acute attacks of demyelinating disease: detecting a Lazarus effect.
    Weinshenker BG
    Ther Apher; 2000 Jun; 4(3):187-9. PubMed ID: 10910016
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclophosphamide and plasma exchange in multiple sclerosis.
    Noseworthy JH; Vandervoort MK; Penman M; Ebers G; Shumak K; Seland TP; Roberts R; Yetisir E; Gent M; Taylor DW
    Lancet; 1991 Jun; 337(8756):1540-1. PubMed ID: 1675382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.